nisoxetine has been researched along with vanoxerine in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (33.33) | 18.2507 |
2000's | 11 (45.83) | 29.6817 |
2010's | 5 (20.83) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banti, I; Giannaccini, G; Giuntini, J; Lapucci, A; Lucacchini, A; Mazzoni, MR; Nencetti, S; Nuti, E; Orlandini, E; Ortore, G; Rossello, A | 1 |
Hahn, HG; Han, M; Jeong, N; Song, C | 1 |
Cox, BM; Izenwasser, S; Jacocks, HM; Werling, LL | 1 |
Cox, BM; Izenwasser, S; Werling, LL | 1 |
Tella, SR | 1 |
Goldberg, SR; Tella, SR | 1 |
Gackenheimer, SL; Gehlert, DR; Robertson, DW | 1 |
Holtzman, SG; Waddell, AB | 1 |
Inazu, M; Kiuchi, Y; Kubota, N; Matsumiya, T; Oguchi, K; Takeda, H; Zhang, J | 1 |
Carroll, FI; French, D; Izenwasser, S; Kunko, PM | 1 |
Brodde, OE; Leineweber, K; Seyfarth, T | 1 |
Brockington, A; Hope, BT; Morón, JA; Rocha, BA; Wise, RA | 1 |
Hirshfeld, A; Mazur, Y; Rehavi, M; Roz, N | 1 |
Bergman, J; Brust, P; Eskola, O; Forsback, S; Grönroos, T; Haaparanta, M; Lehikoinen, P; Marjamäki, P; Solin, O; Steinbach, J; Zessin, J | 1 |
Steketee, JD; Williams, JM | 1 |
Candeletti, S; D'Addario, C; Di Benedetto, M; Feliciani, D; Izenwasser, S; Romualdi, P | 1 |
Cheetham, S; Jenner, P; Lane, EL | 1 |
Dutta, AK; Reith, ME; Wang, LC | 1 |
Diniz, PH; Gomez, MV; Gomez, RS; Guatimosim, C; Silva, JH | 1 |
Fujibayashi, Y; Kanegawa, N; Kawashima, H; Kiyono, Y; Kuge, Y; Saji, H; Sugita, T; Ueda, M | 1 |
Hall, FS; Jones, JD; Rice, K; Riley, AL; Uhl, GR | 1 |
Hahn, HG; Han, M; Han, Y; Shin, D; Song, C | 1 |
Choi, K; Moon, B; Park, JE; Roh, EJ; Sim, T; Song, C | 1 |
Cheon, SH; Choi, K; Hahn, HG; Han, M; Song, C; Yun, J | 1 |
24 other study(ies) available for nisoxetine and vanoxerine
Article | Year |
---|---|
Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
Topics: Animals; Dopamine; Humans; Models, Molecular; Neurotransmitter Agents; Norepinephrine; Piperidines; Protein Binding; Rabbits; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2011 |
Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine.
Topics: | 2014 |
Comparison of dopamine uptake and release in vitro in sheep and rat striatum.
Topics: Animals; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Fluoxetine; In Vitro Techniques; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Sheep | 1991 |
Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex.
Topics: Animals; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluoxetine; In Vitro Techniques; Kinetics; Male; Methylphenidate; Nalidixic Acid; Naphthyridines; Neurotransmitter Uptake Inhibitors; Norepinephrine; Nucleus Accumbens; Olfactory Bulb; Piperazines; Rats; Rats, Inbred Strains | 1990 |
Effects of monoamine reuptake inhibitors on cocaine self-administration in rats.
Topics: Animals; Biogenic Monoamines; Cocaine; Desipramine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Injections, Intravenous; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Reward; Self Administration | 1995 |
Monoamine uptake inhibitors alter cocaine pharmacokinetics.
Topics: Animals; Biotransformation; Cocaine; Desipramine; Dopamine Uptake Inhibitors; Drug Interactions; Fluoxetine; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley | 1993 |
Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites.
Topics: Animals; Atomoxetine Hydrochloride; Binding Sites; Desipramine; Fluoxetine; Kinetics; Ligands; Male; Nerve Tissue Proteins; Norepinephrine; Piperazines; Propylamines; Prosencephalon; Rats; Rats, Sprague-Dawley | 1993 |
Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists.
Topics: Animals; Cisterna Magna; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Injections; Male; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors | 1998 |
Pharmacological characterization of dopamine transport in cultured rat astrocytes.
Topics: Animals; Astrocytes; Biological Transport, Active; Carrier Proteins; Cells, Cultured; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Kinetics; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Sodium; Symporters; Zimeldine | 1999 |
Continuous infusion of selective dopamine uptake inhibitors or cocaine produces time-dependent changes in rat locomotor activity.
Topics: Adrenergic Uptake Inhibitors; Animals; Cocaine; Dopamine Uptake Inhibitors; Drug Tolerance; Fluoxetine; Infusion Pumps, Implantable; Male; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Factors | 1999 |
Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Binding, Competitive; Cocaine; Desipramine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Heart Failure; Heart Ventricles; Hypertrophy; In Vitro Techniques; Male; Membranes; Monocrotaline; Norepinephrine; Piperazines; Rats; Rats, Wistar; Tritium | 2000 |
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Topics: Animals; Brain; Brain Chemistry; Caudate Nucleus; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Frontal Lobe; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Piperazines; Symporters; Synaptosomes | 2002 |
Inhibition of vesicular uptake of monoamines by hyperforin.
Topics: Animals; Anti-Bacterial Agents; Biogenic Monoamines; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Fluoxetine; Hypericum; Male; Neurotransmitter Uptake Inhibitors; Phloroglucinol; Piperazines; Plant Extracts; Prosencephalon; Rats; Synaptosomes; Terpenes | 2002 |
S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.
Topics: Animals; Autoradiography; Brain; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Fluorine Radioisotopes; Fluoxetine; Isoquinolines; Male; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Radioactive Tracers; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Symporters; Tomography, Emission-Computed | 2003 |
Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex.
Topics: Animals; Biological Transport; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Piperazines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Synaptosomes; Time Factors; Tritium | 2004 |
Effects of the selective norepinephrine uptake inhibitor nisoxetine on prodynorphin gene expression in rat CNS.
Topics: Adrenergic Uptake Inhibitors; Animals; Blotting, Northern; Central Nervous System; Cocaine; Dopamine Uptake Inhibitors; Enkephalins; Fluoxetine; Gene Expression; Male; Piperazines; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 2004 |
Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors.
Topics: Animals; Chlorobenzenes; Cyclobutanes; Dopamine Uptake Inhibitors; Fluoxetine; Male; Motor Activity; Norepinephrine; Oxidopamine; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Rotation | 2005 |
Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
Topics: Binding Sites; Binding, Competitive; Brain Chemistry; Buffers; Cell Line; Cell Membrane; Cocaine; Dopamine Uptake Inhibitors; Fluoxetine; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Radioligand Assay; Reproducibility of Results; Symporters; Temperature | 2005 |
Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices.
Topics: Anesthetics, Inhalation; Animals; Cerebral Cortex; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Fluoxetine; Halothane; Male; Nomifensine; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Rats; Rats, Wistar; Tetrodotoxin; Transport Vesicles; Tritium | 2007 |
Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.
Topics: Animals; Binding, Competitive; Desipramine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluoxetine; Heart; Iodine Radioisotopes; Isotope Labeling; Metabolic Clearance Rate; Morpholines; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tissue Distribution | 2008 |
Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Psychological; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Male; Mice; Norepinephrine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Taste | 2009 |
Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Azetidines; Behavior, Animal; Drug Design; HEK293 Cells; Humans; Inhibitory Concentration 50; Mice; Neurotransmitter Uptake Inhibitors | 2012 |
Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Lactams; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Pyrrolidinones; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2013 |
Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.
Topics: Azetidines; Biological Transport; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Neurotransmitter Uptake Inhibitors; Phenyl Ethers; Plasma Membrane Neurotransmitter Transport Proteins; Serotonin; Structure-Activity Relationship | 2014 |